Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.04.2023 | Case report

Gemcitabine

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Wei G, et al. Outcomes, safety and tolerability of intracavitary Jelmyto instillation for low grade upper tract urothelial cancer: The initial Australian experience. BJU International 131 (Suppl. 1) : 75-76, Feb 2023. Available from: URL: http://doi.org/10.1111/bju.15962 [abstract] Wei G, et al. Outcomes, safety and tolerability of intracavitary Jelmyto instillation for low grade upper tract urothelial cancer: The initial Australian experience. BJU International 131 (Suppl. 1) : 75-76, Feb 2023. Available from: URL: http://​doi.​org/​10.​1111/​bju.​15962 [abstract]
Metadaten
Titel
Gemcitabine
Lack of efficacy: case report
Publikationsdatum
01.04.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-36936-0

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Ganciclovir

Case report

Antineoplastics

Case report

Efavirenz

Case report

Aciclovir